Donoghue Forlines’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,382
| Closed | -$626K | – | 268 |
|
|
2022
Q2 | $626K | Sell |
4,382
-689
| -14% | -$98.4K | 0.16% | 166 |
|
|
2022
Q1 | $874K | Buy |
+5,071
| New | +$874K | 0.19% | 171 |
|
|
2021
Q4 | – | Sell |
-2,101
| Closed | -$809K | – | 286 |
|
|
2021
Q3 | $809K | Buy |
2,101
+219
| +12% | +$84.3K | 0.16% | 150 |
|
|
2021
Q2 | $442K | Sell |
1,882
-5,065
| -73% | -$1.19M | 0.08% | 186 |
|
|
2021
Q1 | $910K | Sell |
6,947
-8,299
| -54% | -$1.09M | 0.18% | 137 |
|
|
2020
Q4 | $1.59M | Buy |
+15,246
| New | +$1.59M | 0.31% | 62 |
|
|
2020
Q3 | – | Sell |
-21,795
| Closed | -$1.4M | – | 131 |
|
|
2020
Q2 | $1.4M | Buy |
+21,795
| New | +$1.4M | 0.37% | 52 |
|